Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03229941 · ClinicalTrials.gov registry record · NA
Transfusion Trigger After Operations in High Cardiac Risk Patients
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,424
- Enrollment target
NCT03229941: Completed NA study, sponsored by VA Office of Research and Development.
NCT03229941 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,424 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03229941, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,424 participants
- Enrollment target
Study Summary
The goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb \< 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared to a restrictive transfusion strategy (transfusion trigger at Hb \< 7 gm/dl).
Primary Outcome
MI will be defined using the Third Universal Definition of Myocardial Infarction. Acute renal failure will be defined as Acute Kidney Injury stage III according to RIFLE criteria. Baseline creatinine will be considered the creatinine upon admission prior to the index operation. The above urine output criteria will be only used for patients who are in the ICU and have precise monitoring of their urinary output. For patients on the surgical floor only serum creatinine changes will be used for asse
Interventions
- PROCEDURE Blood Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,424 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2024-03-02 |
| Phase | NA |
What the finished NCT03229941 record still lists
NCT03229941 is an interventional study that assigns participants to a tested intervention. Its 1,424 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Blood Transfusion is the first listed.
NCT03229941 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03229941 about?
NCT03229941 is a clinical study titled "Transfusion Trigger After Operations in High Cardiac Risk Patients". The goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb \< 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared t...
What is the current status of trial NCT03229941?
This trial is currently completed. It is a NA study. The enrollment target is 1,424 participants. The study started on 2018-02-05. Estimated completion is 2024-03-02.
What interventions are being tested in trial NCT03229941?
The interventions under investigation include: Blood Transfusion (PROCEDURE).
Who is sponsoring clinical trial NCT03229941?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03229941's enrollment target sits among peer trials
1,424 70th of 2000 higher than 1,931 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI